CNA Diagnostics

CNA Diagnostics is a molecular diagnostics company focused on the development of early-detection tests for infectious diseases in both veterinary and human health. The company's core technology leverages circulating nucleic acids (CNAs) as biomarkers to identify pathogens and disease states significantly earlier than traditional diagnostic methods. Their lead products target high-impact agricultural conditions such as Johne's disease and Bovine Respiratory Disease (BRD) in cattle. Additionally, the company is exploring the link between Mycobacterium avium subspecies paratuberculosis (MAP) and human conditions like Crohn's disease. CNA Diagnostics aims to provide actionable data for livestock producers and healthcare providers to improve outcomes and reduce economic losses.